We would love to hear your thoughts about our site and services, please take our survey here.
Hopefully this will make things a bit clearer than the rns this morning.
Cannaray Limited, a leading European medical cannabis and wellness CBD company, is today announcing the signing of an exclusive LOI for the listing of its CBD division (Cannaray Brands Ltd and Love CBD Health Ltd) via a reverse takeover of Cellular Goods PLC (LSE: CBX).
Can't see any yet. This should change when they announce contracts.
the update in July says more contracts coming so soon hopefully. reckon that's why they wanted listed on otc in the US first.
Further customers to be announced - the Group is currently engaged with several major US utilities providers with a view to securing near term purchase agreements
Didn't know we had a research note.
https://narfgroup.com/Shard%20(Tennyson)%20Research%20-%20March%202022.pdf
If it can make me feel like that I'll be bathing in it. I'd love to see it your description as a real advert.
Fever Tree results out tomorrow.
Update next Tuesday if it follows the same as last year on the 13th.
Polymetal will release the Group’s H1 2022 financial results on Thursday, September 22
Update this week or next and idiots are selling.
Looks like we're in the right spot.
https://www.einnews.com/pr_news/588436221/tonic-water-market-is-estimated-to-reach-1-168-9-million-by-2027-registering-a-cagr-of-7-3-from-2021-to-2027
Is this the one?
https://www.proactiveinvestors.com.au/ASX:SAU/Southern-Gold-Ltd
Won't have long to wait as update could come anytime in September.
Raised at 10.5p in January.
East Imperial has executed placing letters with institutional and other investors and certain of the Company's directors, to place 32,398,899 shares ("Placing Shares") at 10.5 pence per share, raising gross proceeds of GBP3,401,884.40. The Placing was the result of demand for shares from a number of institutions including Aviva Investors, who subscribed for 9 million shares, taking their total beneficial shareholding in the Company to approximately 26.1 million, or 7.7 percent.
That's a question you can put to them in the webinar if you want.
From May this year,Align
In June 2021, we revisited our target price for BMV. Using a flat gold price of US$1,775 per ounce, we determined a Net Present Value using a 12% discount rate of US$302.56 million. To be more conservative to allow for project execution risk, we discounted this NPV by 50% resulting in a figure of US$151.28 million. This equates to 23.28p per share based on the number of shares in issue (467,482,119). Based on the number of shares on a fully diluted basis (650,901,578 where we included all of SAU’s 200 million shares) gave a figure of 16.72p which we adopted as our new target price.